These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32222451)

  • 1. Evidenced-based guidelines for tuberculosis screening before biologic treatment initiation.
    Shah P; Rebick G; Bajaj S; Desvignes L; Lo Sicco K
    J Am Acad Dermatol; 2020 Jul; 83(1):e25-e26. PubMed ID: 32222451
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Evidence-based guidelines for tuberculosis screening before biologic treatment initiation".
    Fernandez AP; Ellis A; Khanna U; Galadari A
    J Am Acad Dermatol; 2020 Jul; 83(1):e27-e28. PubMed ID: 32222450
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient.
    Rodríguez-Jiménez P; Mir-Viladrich I; Chicharro P; Solano-López G; López-Longo FJ; Taxonera C; Sánchez-Martínez P; Martínez-Lacasa X; García-Gasalla M; Dorca J; Arias-Guillén M; García-García JM; Dauden E
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):584-601. PubMed ID: 29871738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to positive latent tuberculosis infection status is low in patients with hidradenitis suppurativa taking biologic medications.
    Ellis A; Khanna U; Galadari A; Fernandez AP
    J Am Acad Dermatol; 2020 Jul; 83(1):246-248. PubMed ID: 31940465
    [No Abstract]   [Full Text] [Related]  

  • 5. An audit of compliance with tuberculosis screening prior to treatment with biologics in psoriasis.
    Kelly A; Kirby B
    Clin Exp Dermatol; 2018 Jul; 43(5):611. PubMed ID: 29446475
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C; Dehesa L; Vega A; Kerdel F
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to "Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study".
    Khanna U; Fernandez AP
    J Am Acad Dermatol; 2022 Dec; 87(6):1437-1438. PubMed ID: 35995087
    [No Abstract]   [Full Text] [Related]  

  • 8. Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review.
    Lee EB; Amin M; Man J; Egeberg A; Wu JJ
    J Dermatolog Treat; 2018 Nov; 29(7):671-675. PubMed ID: 29455561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?
    Johnson MG; Bialas RW; Hall RP; Stout JE
    J Dermatolog Treat; 2016 Aug; 27(4):378-80. PubMed ID: 26652171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe psoriasis entering remission after treatment for latent tuberculosis with isoniazid: Report of two cases.
    Partarrieu-Mejías F; Hernández-Bel P; Giácaman-von der Weth M; Pérez-Ferriols A
    J Dermatol; 2019 Sep; 46(9):798-801. PubMed ID: 31325342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hepatitis B virus and tuberculosis infection in patients with moderate-to-severe psoriasis recruiting for biological therapy in China.
    Sun XL; Li LF
    Br J Dermatol; 2019 Aug; 181(2):375-376. PubMed ID: 30693484
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study.
    Snast I; Bercovici E; Avni T; Shitenberg D; Hodak E; Pavlovsky L
    Acta Derm Venereol; 2018 Nov; 98(10):979-980. PubMed ID: 30085327
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study".
    Ruggiero A; Potestio L; Camela E; Fabbrocini G; Megna M
    J Am Acad Dermatol; 2022 Dec; 87(6):e239-e240. PubMed ID: 35948168
    [No Abstract]   [Full Text] [Related]  

  • 15. [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF-alpha inhibitors in psoriasis patients].
    Goujon C; Gormand F; Gunera-Saad N; Dahel K; Vial T; Nicolas JF
    Ann Dermatol Venereol; 2010; 137(6-7):437-43. PubMed ID: 20620572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
    Amerio P; Amoruso G; Bardazzi F; Campanati A; Cassano N; Conti A; Gisondi P; Guarneri C; Mazzotta A; Piaserico S; Prestinari F; Prignano F; Zane C; de Simone C
    J Dermatolog Treat; 2013 Aug; 24(4):305-11. PubMed ID: 22208431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Latent Tuberculosis in the Patient With Moderate to Severe Psoriasis Who Is a Candidate for Systemic and/or Biologic Therapy.
    Martínez-López A; Rodriguez-Granger J; Ruiz-Villaverde R
    Actas Dermosifiliogr; 2016 Apr; 107(3):207-14. PubMed ID: 26651325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report.
    Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Tolino E; Zuber S; Potenza C
    Cutis; 2012 Sep; 90(3):120-2. PubMed ID: 23094309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy.
    Elston DM
    J Am Acad Dermatol; 2022 Oct; 87(4):747-748. PubMed ID: 35643245
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting.
    Conti A; Piaserico S; Gisondi P; Odorici G; Galdo G; Lasagni C; Pellacani G
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28547750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.